Highland Therapeutics' Seed Round

Highland Therapeutics raised a round of funding on August 16, 2013.

Highland Therapeutics, a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, is leveraging its proprietary technology, DELEXIS, to optim…

Articles about Highland Therapeutics' Seed Round: